The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
The U.S. Food and Drug Administration banned the dye known as Red 3 from the nation’s food supply in January, setting ...
Car manufacturers are increasingly using subscriptions and paywalled features to generate revenue, but some tactics are ...
Apple will work with Chinese tech giant Alibaba to roll out AI services in the world’s biggest market for mobile phones, in a move that removes ...
The industry is poised for significant growth in 2025, fuelled by robust digital revenues and shifting consumer behaviors. Media experts weigh in.
The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...
3don MSN
TOKYO (AP) — Japanese technology company SoftBank Group Corp. reported a 369.2 billion yen ($2.4 billion) loss for the fiscal ...
Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.
Markets on Wall Street leaned toward small losses early Friday as investors took in more corporate earnings while waiting for the government’s January report on retail sales. Futures for the ...
Duracell, one of the world’s leading battery manufacturers, unveiled its first-ever creative ad spot during the big game on Sunday. The brand shocked ...
The Protecting America Initiative tackles the issue in the ad by reminding viewers that President Donald Trump in 2019 had ...
4d
Live Science on MSNHims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results